Effects of Simvastatin and omega-3 fatty acids on plasma lipoproteins and lipid peroxidation in patients with combined hyperlipidaemia

Journal of Internal Medicine

Volumn 243, Issue 2, 1998, Pages 163-170

  Nordoy A ^a,c   Bonaa, K H ^a   Nilsen, H ^a   Berge, R K ^b   Hansen, J B ^a   Ingebretsen, O C ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c Regionsykehuset ^*  (Norway)

Author keywords

Combined hyperlipidemia; Lipid peroxides; Omega 3 fatty acids; Serum lipids; Simvastatin

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL; CORN OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPID PEROXIDE; LIPOPROTEIN; OMEGA 3 FATTY ACID; PLACEBO; POLYUNSATURATED FATTY ACID; SIMVASTATIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTILIPEMIC AGENTS; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; HYPERLIPIDEMIAS; LIPID PEROXIDATION; LIPIDS; MALE; MIDDLE AGED; SIMVASTATIN; TREATMENT OUTCOME;

EID: 0031959846     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1998.00297.x     Document Type: Article

References (36)

1. The National Cholesterol Education Program (NCEP). Expert panel on Detection. Evaluation Treatment High Blood Cholesterol in Adults (summary). JAMA 1993; 269: 3015-23.
2. NIH Consensus Conference. Triglyceride, high-density lipoprotein, and coronary heart disease. JAMA 1993; 269: 505-10.
3. Musliner TA, Krauss RM. Lipoprotein subspecies and risk of coronary disease. Clin LChem 1988: 34: B78-83.
4. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes 1988: 37: 1595-607.
5. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, McFarlane PW et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995: 333: 1301-7.
6. The Scandinavian Simvastatin Survival Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease. Scandinavian Simvastatin Survival Study. (45) Lancet 1994; 344: 1383-9.
7. Gould AL. Rossouw JE, Santanello NC, Heyse JF, Furberg CD. Cholesterol reduction yields clinical benefit. Circulation 1995; 91: 2274-82.
8. Contacos C. Barter PJ, Sullivan DR. Effect of pravastalin and ω-3 fatty acids on plasma lipids and lipoproteins in patients with combined hyperlipidemia. Arteriosel Thrombos 1993; 13: 1755-62.
9. Reaven P. The role of dietary fat in LDL oxidation and atherosclerosis. Nutr Metab Cardiovasc Dis 1996; 6: 57-64.
10. Blaker B, Rimestad AH. Food Composition Tables. Oslo, Norway: National Nutrition Council 1991.
11. Rimestad AH, Trygg K. Food Composition Tables (Suppl. 2). Oslo, Norway: National Nutrition Council 1988.
12. Jorde R. Burhol PG, Sehultz TB. Waldum HL. Lygren I, Jenssen T. et al. The effect of a 34-h fast on meal-induced rises in plasma GIP, serum insulin and blood glucose in man. Scand J Gastritenterol 1981; 16: 109-12.
13. Burstein M, Scholnick HR, Morfin R. Rapid method for isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970: 11: 585-95.
14. James E, Hixson. Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990; 31: 545-8.
15. Strand H, Ingebrigtsen M, Ingebretsen OC. Restriction fragment analysis by HPLC in apolipoprotein E genotyping. Clin Chem 1997:43:271.
16. Redgrave TG, Roberts DC, West CE. Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal Biochem 1975;65:42-9.
17. Folch J, Lees M, Stanley SA. simple method for isolation and purification of total lipids from animal tissue. J Biol Chem 1957;226:497-509.
18. Kaluzny MA, Duncan LA, Merritt MV, Epps DE. Rapid separation of lipid classes in high yield and purity using bonded phase columns. J Lipid Res 1985; 26: 135-40.
19. Yagi K. Assay for serum lipid peroxide level, its clinical significance. In: Lipid Peroxides in Biology and Medicine. K. Yagi (ed.) New York. Academic Press 1982; 223-42.
20. Chiu HC, Jeng JR, Shich SM. Increased oxidizabilily of plasma lowdensity lipoprotein from patients with coronary artery disease. Biochim Biophys Acta 1994; 1225: 200-8.
21. El-Saadani M, Estebauer H, El-Sayed M, Coher M. Nassar AY. Jurgens GA. spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 1989: 30: 627-30.
22. Seta K, Nakamura H, Okuyama T. Determination of α-tocopherol, free cholesterol, esterified cholesterol and triacylglycerols in human lipoproteins by high-performance liquid chromatography. J Chromatogr 1990; 515: 585-95.
23. Arnaud J. Fortis I, Blachier S, Kia D, Favier A. Simultaneous determination of retinol. α-tocopherol and β-carotene in serum by isocratic high-performance liquid chromatography. J Chromatogr 1991; 572: 103-16.
24. Sierra C. Pastor MC, de Ramon M. Liquid chromatography determination of a-tocopherol in erythrocytes. Clin Chim Acta 1992; 208: 119-26.
25. SAS Institute Inc. SAS/STAT guide for personal computers. Version 6 edn. Cary, N.C: SAS Institute, 1987.
26. Harris WS. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 1989; 30: 785-807.
27. Kasmin-Karakas SE. Herrmann R, Almario R. Effects of omega-3 fatty acids on intravascular lipolysis of very-low-density lipoproteins in humans. Metabolism 1995;44: 1223-30.
28. Lussier-Cacan S. Dubreuil-Quidoz S. Roederer G, Leboeuf N, Boulet L. de Langavant GC. et al. Influence of probucol on enhanced LDL oxidation after fish oil treatment of hyper-triglyceridemic patients. Arterioscl Thrombos 1993: 13: 1790-6.
29. Nordoy A. Hatcher LF, Ullmann DL, Connor WE. Individual effects of dietary saturated fatty acids and fish oil on plasma lipids and lipoproteins in man. Am J Clin Nutr 1993; 57: 634-9.
30. Mazzone T, Apolipoprotein E. secretions by macrophages: its potential physiological function. Curr Opin Lipid 1996; 7: 303-7.
31. Witztum JL. Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1992; 88: 1785-92.
32. Nenseter MS, Drevon CA. Dietary polyunsaturated and peroxidation of low density lipoprotein. Curr Opinon Lipid 1995: 6: 167-71.
33. Nordoy A, Goodnight SH. Dietary lipids and thrombosis. Relationship To Atherosclerosis. Arteriosclerosis 1990: 10: 149-63.
34. Tobert JA. Efficacy an long term adverse effect pattern on lovastatin. Am J Cardiol 1988: 62: 28-34.
35. Pierce LR, Wysowski DK, Gross TP. Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy. JAMA 1990; 264: 71-5.
36. Hansen JB, Lyngmo V, Svensson B, Nordoy A. Inhibition of exercise-induced shortening of bleeding time by fish oil in familial hypercholesterolemia (Type IIa). Arterioscl Thrombos 1993; 13, nr. 1:98-104.